Answers are grounded in this paper and cite their sources.
Abnormalities in serum potassium contribute disproportionately to the high death risk in PD patients. This may, in part, account for the equivalent cardiac risk seen with the two therapies.
No takes yet. Share an insight, caveat, or question.
Torlén et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: